102 related articles for article (PubMed ID: 17897880)
1. Yersinia as oral live carrier vaccine: influence of Yersinia outer proteins (Yops) on the T-cell response.
Trülzsch K; Sporleder T; Leibiger R; Rüssmann H; Heesemann J
Int J Med Microbiol; 2008 Jan; 298(1-2):59-67. PubMed ID: 17897880
[TBL] [Abstract][Full Text] [Related]
2. Yersinia enterocolitica Yop mutants as oral live carrier vaccines.
Leibiger R; Niedung K; Geginat G; Heesemann J; Trülzsch K
Vaccine; 2008 Dec; 26(51):6664-70. PubMed ID: 18822332
[TBL] [Abstract][Full Text] [Related]
3. Attenuated recombinant Yersinia as live oral vaccine carrier to protect against amoebiasis.
Lotter H; Rüssmann H; Heesemann J; Tannich E
Int J Med Microbiol; 2008 Jan; 298(1-2):79-86. PubMed ID: 17900982
[TBL] [Abstract][Full Text] [Related]
4. Induction of CD8+ T cell responses by Yersinia vaccine carrier strains.
Wiedig CA; Kramer U; Garbom S; Wolf-Watz H; Autenrieth IB
Vaccine; 2005 Oct; 23(42):4984-98. PubMed ID: 15985316
[TBL] [Abstract][Full Text] [Related]
5. "One size fits it all": translocation of foreign antigens by Yersinia type III secretion system (TTSS) leads to concomitant CD4 and CD8 T-cell priming.
Rüssmann H; Panthel K
Int J Med Microbiol; 2004 Oct; 294(5):313-7. PubMed ID: 15532990
[TBL] [Abstract][Full Text] [Related]
6. Yersinia enterocolitica: subversion of adaptive immunity and implications for vaccine development.
Autenrieth SE; Autenrieth IB
Int J Med Microbiol; 2008 Jan; 298(1-2):69-77. PubMed ID: 17702651
[TBL] [Abstract][Full Text] [Related]
7. Listeria monocytogenes as novel carrier system for the development of live vaccines.
Schoen C; Loeffler DI; Frentzen A; Pilgrim S; Goebel W; Stritzker J
Int J Med Microbiol; 2008 Jan; 298(1-2):45-58. PubMed ID: 17936682
[TBL] [Abstract][Full Text] [Related]
8. Yersinia enterocolitica-mediated translocation of defined fusion proteins to the cytosol of mammalian cells results in peptide-specific MHC class I-restricted antigen presentation.
Rüssmann H; Weissmüller A; Geginat G; Igwe EI; Roggenkamp A; Bubert A; Goebel W; Hof H; Heesemann J
Eur J Immunol; 2000 May; 30(5):1375-84. PubMed ID: 10820384
[TBL] [Abstract][Full Text] [Related]
9. Effector functions of pathogenic Yersinia species.
Aepfelbacher M; Trasak C; Ruckdeschel K
Thromb Haemost; 2007 Sep; 98(3):521-9. PubMed ID: 17849040
[TBL] [Abstract][Full Text] [Related]
10. Development of a tripartite vector system for live oral immunization using a gram-negative probiotic carrier.
Buddenborg C; Daudel D; Liebrecht S; Greune L; Humberg V; Schmidt MA
Int J Med Microbiol; 2008 Jan; 298(1-2):105-14. PubMed ID: 17936683
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory Yersinia outer proteins (Yops)-useful tools for bacteria and humans alike.
Grabowski B; Schmidt MA; Rüter C
Virulence; 2017 Oct; 8(7):1124-1147. PubMed ID: 28296562
[TBL] [Abstract][Full Text] [Related]
12. Inverted pathogenicity: the use of pathogen-specific molecular mechanisms for prevention or therapy of disease.
Rüssmann H
Int J Med Microbiol; 2004 Apr; 293(7-8):565-9. PubMed ID: 15149032
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulation of macrophages by pathogenic Yersinia species.
Ruckdeschel K
Arch Immunol Ther Exp (Warsz); 2002; 50(2):131-7. PubMed ID: 12022702
[TBL] [Abstract][Full Text] [Related]
14. Yersinia outer protein E, YopE. A versatile type III effector molecule for cytosolic targeting of heterologous antigens by attenuated Salmonella.
Rüssmann H
Adv Exp Med Biol; 2003; 529():407-13. PubMed ID: 12756799
[TBL] [Abstract][Full Text] [Related]
15. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
[TBL] [Abstract][Full Text] [Related]
16. Oral vaccination with recombinant Yersinia enterocolitica expressing hybrid type III proteins protects gerbils from amebic liver abscess.
Lotter H; Rüssmann H; Heesemann J; Tannich E
Infect Immun; 2004 Dec; 72(12):7318-21. PubMed ID: 15557659
[TBL] [Abstract][Full Text] [Related]
17. The tranquilizing injection of Yersinia proteins: a pathogen's strategy to resist host defense.
Aepfelbacher M; Zumbihl R; Ruckdeschel K; Jacobi CA; Barz C; Heesemann J
Biol Chem; 1999; 380(7-8):795-802. PubMed ID: 10494828
[TBL] [Abstract][Full Text] [Related]
18. SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria.
Nagarajan AG; Balasundaram SV; Janice J; Karnam G; Eswarappa SM; Chakravortty D
Vaccine; 2009 May; 27(21):2804-11. PubMed ID: 19428891
[TBL] [Abstract][Full Text] [Related]
19. Functions of the Yersinia effector proteins in inhibiting host immune responses.
Navarro L; Alto NM; Dixon JE
Curr Opin Microbiol; 2005 Feb; 8(1):21-7. PubMed ID: 15694853
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Rho GTPases by type III secretion system translocated effectors of Yersinia.
Aepfelbacher M
Rev Physiol Biochem Pharmacol; 2004; 152():65-77. PubMed ID: 15378389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
